NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/05/2021
Back to search
Official data from USPTO
HEMOLIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/05/2021
Trademark type
Word
Nice classes
5
Filing date
07/09/1999
Registration date
10/16/2001
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/05/2021
Last transaction
08/05/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/01/2000
First use in commerce
12/01/2000
Drawing code
1
Owner type
03
Owner location
Santa Monica, CA
Examiner
SMITH, BRIDGETT
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
HEMOPET
Representatives
Charles Berman GREENBERG TRAURIG LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Veterinary preparations for the treatment of various illnessesblood immune disordersinfectious diseasescancershock and injuries requiring blood replacement for all mammalsdogscatsequinebovinezoo animalswildlife
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/05/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/05/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/03/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
04/20/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/30/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/20/2010
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/20/2010
E89R
TEAS SECTION 8 & 9 RECEIVED
11/15/2010
CFIT
CASE FILE IN TICRS
01/24/2007
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/20/2007
PLGL
ASSIGNED TO PARALEGAL
12/20/2006
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/20/2006
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/19/2006
E815
TEAS SECTION 8 & 15 RECEIVED
10/19/2006
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
10/16/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/23/2001
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/29/2001
IUAF
USE AMENDMENT FILED
01/29/2001
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/10/2000
PUBO
PUBLISHED FOR OPPOSITION
07/18/2000
NPUB
NOTICE OF PUBLICATION
06/16/2000
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2000
CNEA
EXAMINER'S AMENDMENT MAILED
02/22/2000
CNEA
EXAMINER'S AMENDMENT MAILED
01/12/2000
CNRT
NON-FINAL ACTION MAILED
10/18/1999
DOCK
ASSIGNED TO EXAMINER
09/29/1999
Continuous trademark protection
Get notified about every new filing that threatens HEMOLIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.